Back to Authors

Chao, Michael

Mayo Clinic

Icahn School of Medicine at Mount Sinai

Citations 1

The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
Reyes‐Dumeyer, Dolly, Faber, Kelley, Vardarajan, Badri, Goate, Alison, Renton, Alan, Chao, Michael, Boeve, Brad, Cruchaga, Carlos, Pericak‐Vance, Margaret, Haines, Jonathan L., Rosenberg, Roger, Tsuang, Debby, Sweet, Robert A., Bennett, David A., Wilson, Robert S., Foroud, Tatiana, Mayeux, Richard, Goate, Alison , Bennett, David A. , Cruchaga, Carlos , Wilson, Robert S. , Bennett, David A. , Cruchaga, Carlos , Goate, Alison M , Reyes‐Dumeyer, Dolly, Faber, Kelley, Vardarajan, Badri, Renton, Alan, Chao, Michael, Boeve, Brad, Pericak‐Vance, Margaret, Haines, Jonathan L., Rosenberg, Roger, Tsuang, Debby, Sweet, Robert A., Bennett, David A., Wilson, Robert S., Foroud, Tatiana, Mayeux, Richard

Alzheimer's & Dementia | January 3, 2022 | Volume: 18 | Issue: 10 | Pages: 1889-1897

10.1002/alz.12514 Get It

Abstract Introduction The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study (NIA‐LOAD FBS) was established to study the genetic etiology of Alzheimer's disease (AD). Methods Recruitment focused on families with two living affected siblings and a third first‐degree relative similar in age with or without dementia. Uniform assessments were completed, DNA was obtained, as was neuropathology, when possible. Apolipoprotein E ( APOE ) genotypes, genome‐wide single nucleotide polymorphism (SNP) arrays, and sequencing was completed in most families. Results APOE genotype modified the age‐at‐onset in many large families. Novel variants and known variants associated with early‐ and late‐onset AD and frontotemporal dementia were identified supporting an international effort to solve AD genetics. Discussion The NIA‐LOAD FBS is the largest collection of familial AD worldwide, and data or samples have been included in 123 publications addressing the genetic etiology of AD. Genetic heterogeneity and variability in the age‐at‐onset provides opportunities to investigate the complexity of familial AD.